Report Detail

Medical Devices & Consumables Global Medical Transdermal Drug Delivery System Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4573746
  • |
  • 02 January, 2024
  • |
  • Global
  • |
  • 135 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Medical Transdermal Drug Delivery System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
A transdermal drug delivery system (TTS), or transdermal patch, is a way for drugs to be absorbed into the body through the skin. TTS is a very useful form of drug delivery with many advantages. One is that when the patch is attached to the skin, drug administration can be visually confirmed. Additionally, these formulations are designed to control the rate of drug absorption, helping to maintain blood levels over a longer period of time.
The Global Info Research report includes an overview of the development of the Medical Transdermal Drug Delivery System industry chain, the market status of Prescription Drugs (Fentanyl, Nitroglycerin), Non-prescription Drugs (Fentanyl, Nitroglycerin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medical Transdermal Drug Delivery System.
Regionally, the report analyzes the Medical Transdermal Drug Delivery System markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medical Transdermal Drug Delivery System market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Medical Transdermal Drug Delivery System market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medical Transdermal Drug Delivery System industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Fentanyl, Nitroglycerin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medical Transdermal Drug Delivery System market.
Regional Analysis: The report involves examining the Medical Transdermal Drug Delivery System market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medical Transdermal Drug Delivery System market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Medical Transdermal Drug Delivery System:
Company Analysis: Report covers individual Medical Transdermal Drug Delivery System manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medical Transdermal Drug Delivery System This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prescription Drugs, Non-prescription Drugs).
Technology Analysis: Report covers specific technologies relevant to Medical Transdermal Drug Delivery System. It assesses the current state, advancements, and potential future developments in Medical Transdermal Drug Delivery System areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medical Transdermal Drug Delivery System market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Medical Transdermal Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Others
Market segment by Application
Prescription Drugs
Non-prescription Drugs
Major players covered
3M
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Laboratoires Genevrier
Haw Par
Nichiban
Mentholatum
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Transdermal Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Transdermal Drug Delivery System, with price, sales, revenue and global market share of Medical Transdermal Drug Delivery System from 2018 to 2023.
Chapter 3, the Medical Transdermal Drug Delivery System competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Transdermal Drug Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Transdermal Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Transdermal Drug Delivery System.
Chapter 14 and 15, to describe Medical Transdermal Drug Delivery System sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Medical Transdermal Drug Delivery System
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Transdermal Drug Delivery System Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Fentanyl
    • 1.3.3 Nitroglycerin
    • 1.3.4 Estradiol
    • 1.3.5 Nicotine
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Transdermal Drug Delivery System Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Prescription Drugs
    • 1.4.3 Non-prescription Drugs
  • 1.5 Global Medical Transdermal Drug Delivery System Market Size & Forecast
    • 1.5.1 Global Medical Transdermal Drug Delivery System Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Medical Transdermal Drug Delivery System Sales Quantity (2018-2029)
    • 1.5.3 Global Medical Transdermal Drug Delivery System Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 3M
    • 2.1.1 3M Details
    • 2.1.2 3M Major Business
    • 2.1.3 3M Medical Transdermal Drug Delivery System Product and Services
    • 2.1.4 3M Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 3M Recent Developments/Updates
  • 2.2 Hisamitsu
    • 2.2.1 Hisamitsu Details
    • 2.2.2 Hisamitsu Major Business
    • 2.2.3 Hisamitsu Medical Transdermal Drug Delivery System Product and Services
    • 2.2.4 Hisamitsu Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Hisamitsu Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Medical Transdermal Drug Delivery System Product and Services
    • 2.3.4 Mylan Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK Medical Transdermal Drug Delivery System Product and Services
    • 2.4.4 GSK Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 GSK Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Medical Transdermal Drug Delivery System Product and Services
    • 2.5.4 Novartis Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teve (Actavis)
    • 2.6.1 Teve (Actavis) Details
    • 2.6.2 Teve (Actavis) Major Business
    • 2.6.3 Teve (Actavis) Medical Transdermal Drug Delivery System Product and Services
    • 2.6.4 Teve (Actavis) Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Teve (Actavis) Recent Developments/Updates
  • 2.7 Johnson & Johnson
    • 2.7.1 Johnson & Johnson Details
    • 2.7.2 Johnson & Johnson Major Business
    • 2.7.3 Johnson & Johnson Medical Transdermal Drug Delivery System Product and Services
    • 2.7.4 Johnson & Johnson Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Johnson & Johnson Recent Developments/Updates
  • 2.8 Lohmann
    • 2.8.1 Lohmann Details
    • 2.8.2 Lohmann Major Business
    • 2.8.3 Lohmann Medical Transdermal Drug Delivery System Product and Services
    • 2.8.4 Lohmann Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Lohmann Recent Developments/Updates
  • 2.9 Teikoku Seiyaku
    • 2.9.1 Teikoku Seiyaku Details
    • 2.9.2 Teikoku Seiyaku Major Business
    • 2.9.3 Teikoku Seiyaku Medical Transdermal Drug Delivery System Product and Services
    • 2.9.4 Teikoku Seiyaku Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Teikoku Seiyaku Recent Developments/Updates
  • 2.10 Bayer
    • 2.10.1 Bayer Details
    • 2.10.2 Bayer Major Business
    • 2.10.3 Bayer Medical Transdermal Drug Delivery System Product and Services
    • 2.10.4 Bayer Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Bayer Recent Developments/Updates
  • 2.11 Lingrui
    • 2.11.1 Lingrui Details
    • 2.11.2 Lingrui Major Business
    • 2.11.3 Lingrui Medical Transdermal Drug Delivery System Product and Services
    • 2.11.4 Lingrui Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Lingrui Recent Developments/Updates
  • 2.12 Sanofi
    • 2.12.1 Sanofi Details
    • 2.12.2 Sanofi Major Business
    • 2.12.3 Sanofi Medical Transdermal Drug Delivery System Product and Services
    • 2.12.4 Sanofi Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Sanofi Recent Developments/Updates
  • 2.13 Qizheng
    • 2.13.1 Qizheng Details
    • 2.13.2 Qizheng Major Business
    • 2.13.3 Qizheng Medical Transdermal Drug Delivery System Product and Services
    • 2.13.4 Qizheng Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Qizheng Recent Developments/Updates
  • 2.14 Endo
    • 2.14.1 Endo Details
    • 2.14.2 Endo Major Business
    • 2.14.3 Endo Medical Transdermal Drug Delivery System Product and Services
    • 2.14.4 Endo Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Endo Recent Developments/Updates
  • 2.15 Laboratoires Genevrier
    • 2.15.1 Laboratoires Genevrier Details
    • 2.15.2 Laboratoires Genevrier Major Business
    • 2.15.3 Laboratoires Genevrier Medical Transdermal Drug Delivery System Product and Services
    • 2.15.4 Laboratoires Genevrier Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Laboratoires Genevrier Recent Developments/Updates
  • 2.16 Haw Par
    • 2.16.1 Haw Par Details
    • 2.16.2 Haw Par Major Business
    • 2.16.3 Haw Par Medical Transdermal Drug Delivery System Product and Services
    • 2.16.4 Haw Par Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Haw Par Recent Developments/Updates
  • 2.17 Nichiban
    • 2.17.1 Nichiban Details
    • 2.17.2 Nichiban Major Business
    • 2.17.3 Nichiban Medical Transdermal Drug Delivery System Product and Services
    • 2.17.4 Nichiban Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Nichiban Recent Developments/Updates
  • 2.18 Mentholatum
    • 2.18.1 Mentholatum Details
    • 2.18.2 Mentholatum Major Business
    • 2.18.3 Mentholatum Medical Transdermal Drug Delivery System Product and Services
    • 2.18.4 Mentholatum Medical Transdermal Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Mentholatum Recent Developments/Updates

3 Competitive Environment: Medical Transdermal Drug Delivery System by Manufacturer

  • 3.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Medical Transdermal Drug Delivery System Revenue by Manufacturer (2018-2023)
  • 3.3 Global Medical Transdermal Drug Delivery System Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Medical Transdermal Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Medical Transdermal Drug Delivery System Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Medical Transdermal Drug Delivery System Manufacturer Market Share in 2022
  • 3.5 Medical Transdermal Drug Delivery System Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Transdermal Drug Delivery System Market: Region Footprint
    • 3.5.2 Medical Transdermal Drug Delivery System Market: Company Product Type Footprint
    • 3.5.3 Medical Transdermal Drug Delivery System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Transdermal Drug Delivery System Market Size by Region
    • 4.1.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Medical Transdermal Drug Delivery System Consumption Value by Region (2018-2029)
    • 4.1.3 Global Medical Transdermal Drug Delivery System Average Price by Region (2018-2029)
  • 4.2 North America Medical Transdermal Drug Delivery System Consumption Value (2018-2029)
  • 4.3 Europe Medical Transdermal Drug Delivery System Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Medical Transdermal Drug Delivery System Consumption Value (2018-2029)
  • 4.5 South America Medical Transdermal Drug Delivery System Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Medical Transdermal Drug Delivery System Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 5.2 Global Medical Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
  • 5.3 Global Medical Transdermal Drug Delivery System Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 6.2 Global Medical Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
  • 6.3 Global Medical Transdermal Drug Delivery System Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 7.2 North America Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 7.3 North America Medical Transdermal Drug Delivery System Market Size by Country
    • 7.3.1 North America Medical Transdermal Drug Delivery System Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Medical Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 8.2 Europe Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 8.3 Europe Medical Transdermal Drug Delivery System Market Size by Country
    • 8.3.1 Europe Medical Transdermal Drug Delivery System Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Medical Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Medical Transdermal Drug Delivery System Market Size by Region
    • 9.3.1 Asia-Pacific Medical Transdermal Drug Delivery System Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Medical Transdermal Drug Delivery System Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 10.2 South America Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 10.3 South America Medical Transdermal Drug Delivery System Market Size by Country
    • 10.3.1 South America Medical Transdermal Drug Delivery System Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Medical Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Medical Transdermal Drug Delivery System Market Size by Country
    • 11.3.1 Middle East & Africa Medical Transdermal Drug Delivery System Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Medical Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Medical Transdermal Drug Delivery System Market Drivers
  • 12.2 Medical Transdermal Drug Delivery System Market Restraints
  • 12.3 Medical Transdermal Drug Delivery System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Transdermal Drug Delivery System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Transdermal Drug Delivery System
  • 13.3 Medical Transdermal Drug Delivery System Production Process
  • 13.4 Medical Transdermal Drug Delivery System Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Transdermal Drug Delivery System Typical Distributors
  • 14.3 Medical Transdermal Drug Delivery System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Transdermal Drug Delivery System. Industry analysis & Market Report on Medical Transdermal Drug Delivery System is a syndicated market report, published as Global Medical Transdermal Drug Delivery System Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Medical Transdermal Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,745.72
    4,118.58
    5,491.44
    3,215.52
    4,823.28
    6,431.04
    523,635.60
    785,453.40
    1,047,271.20
    288,526.80
    432,790.20
    577,053.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report